What is KeifeRx?
Headquartered in Mclean, VA, KeifeRx is a biotechnology firm dedicated to advancing treatments for neurodegenerative diseases. The company's focus on this critical area of medical research positions it within a rapidly evolving and highly impactful sector of the healthcare industry. KeifeRx aims to leverage its scientific expertise to develop novel therapeutic solutions.
How much funding has KeifeRx raised?
KeifeRx has raised a total of $6M across 1 funding round:
Series A
$6M
Series A (2021): $6M, investors not publicly disclosed
What's next for KeifeRx?
The recent major strategic investment signals a pivotal growth phase for KeifeRx, likely enabling the company to accelerate its research and development pipelines, expand its clinical trial capabilities, and potentially scale its operations. This infusion of capital is expected to fuel innovation and drive the company closer to bringing its neurodegenerative disease therapies to market, marking a significant step in its enterprise-level development.
See full KeifeRx company page